BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32524720)

  • 1. Fasting parameters for estimation of stimulated β cell function in islet transplant recipients with or without basal insulin treatment.
    Uitbeijerse BS; Nijhoff MF; Sont JK; de Koning EJP
    Am J Transplant; 2021 Jan; 21(1):297-306. PubMed ID: 32524720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive Value of C-Peptide Measures for Clinical Outcomes of β-Cell Replacement Therapy in Type 1 Diabetes: Report From the Collaborative Islet Transplant Registry (CITR).
    Baidal DA; Ballou CM; Rickels MR; Berney T; Pattou F; Payne EH; Barton FB; Alejandro R;
    Diabetes Care; 2023 Apr; 46(4):697-703. PubMed ID: 36657975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the BETA-2 Score: An Improved Tool to Estimate Beta Cell Function After Clinical Islet Transplantation Using a Single Fasting Blood Sample.
    Forbes S; Oram RA; Smith A; Lam A; Olateju T; Imes S; Malcolm AJ; Shapiro AM; Senior PA
    Am J Transplant; 2016 Sep; 16(9):2704-13. PubMed ID: 27017888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of simple indices using a single fasting blood sample to estimate beta cell function after islet transplantation.
    Gołębiewska JE; Solomina J; Thomas C; Kijek MR; Bachul PJ; Basto L; Gołąb K; Wang LJ; Fillman N; Tibudan M; Ciepły K; Philipson L; Dębska-Ślizień A; Millis JM; Fung J; Witkowski P
    Am J Transplant; 2018 Apr; 18(4):990-997. PubMed ID: 29218834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species incompatibilities in the pig-to-macaque islet xenotransplant model affect transplant outcome: a comparison with allotransplantation.
    Graham ML; Bellin MD; Papas KK; Hering BJ; Schuurman HJ
    Xenotransplantation; 2011; 18(6):328-42. PubMed ID: 22168140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of metabolic responses to the mixed meal tolerance test vs the oral glucose tolerance test after successful clinical islet transplantation.
    Forbes S; Lam A; Koh A; Imes S; Dinyari P; Malcolm AJ; Shapiro AMJ; Senior PA
    Clin Transplant; 2018 Aug; 32(8):e13301. PubMed ID: 29851179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of an intrinsic relationship between endogenous C-peptide concentration and determinants of glycemic control in type 1 diabetes following islet transplantation.
    Brooks AM; Oram R; Home P; Steen N; Shaw JA
    Diabetes Care; 2015 Jan; 38(1):105-12. PubMed ID: 25422169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-score: an assessment of beta-cell function after islet transplantation.
    Ryan EA; Paty BW; Senior PA; Lakey JR; Bigam D; Shapiro AM
    Diabetes Care; 2005 Feb; 28(2):343-7. PubMed ID: 15677790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early metabolic markers of islet allograft dysfunction.
    Baidal DA; Faradji RN; Messinger S; Froud T; Monroy K; Ricordi C; Alejandro R
    Transplantation; 2009 Mar; 87(5):689-97. PubMed ID: 19295313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor insulin use predicts beta-cell function after islet transplantation.
    Shapey IM; Summers A; Yiannoullou P; Khambalia H; Fullwood C; Hanley NA; Casey J; Forbes S; Rosenthal M; Johnson PR; Choudhary P; Bushnell J; Shaw JAM; Augustine T; Rutter MK; van Dellen D
    Diabetes Obes Metab; 2020 Oct; 22(10):1874-1879. PubMed ID: 32452110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry.
    Chetboun M; Drumez E; Ballou C; Maanaoui M; Payne E; Barton F; Kerr-Conte J; Vantyghem MC; Piemonti L; Rickels MR; Labreuche J; Pattou F;
    Lancet Diabetes Endocrinol; 2023 Jun; 11(6):391-401. PubMed ID: 37105208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of islet mass, number of transplants, and time between transplants on graft function in a national islet transplant program.
    Forbes S; Flatt AJ; Bennett D; Crookston R; Pimkova M; Birtles L; Pernet A; Wood RC; Burling K; Barker P; Counter C; Lumb A; Choudhary P; Rutter MK; Rosenthal M; Sutherland A; Casey J; Johnson P; Shaw JAM
    Am J Transplant; 2022 Jan; 22(1):154-164. PubMed ID: 34355503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Islet Size Really Influence Graft Function After Clinical Islet Transplantation?
    Hughes SJ; Bateman PA; Cross SE; Brandhorst D; Brandhorst H; Spiliotis I; Ballav C; Rosenthal M; Rutter MK; Shaw J; Gough S; Johnson PRV
    Transplantation; 2018 Nov; 102(11):1857-1863. PubMed ID: 30063695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting islet yield in pediatric patients undergoing pancreatectomy and autoislet transplantation for chronic pancreatitis.
    Bellin MD; Blondet JJ; Beilman GJ; Dunn TB; Balamurugan AN; Thomas W; Sutherland DE; Moran A
    Pediatr Diabetes; 2010 Jun; 11(4):227-34. PubMed ID: 19708905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.
    Ryan EA; Lakey JR; Rajotte RV; Korbutt GS; Kin T; Imes S; Rabinovitch A; Elliott JF; Bigam D; Kneteman NM; Warnock GL; Larsen I; Shapiro AM
    Diabetes; 2001 Apr; 50(4):710-9. PubMed ID: 11289033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of exenatide in islet transplant recipients with chronic allograft dysfunction: safety, efficacy, and metabolic effects.
    Froud T; Faradji RN; Pileggi A; Messinger S; Baidal DA; Ponte GM; Cure PE; Monroy K; Mendez A; Selvaggi G; Ricordi C; Alejandro R
    Transplantation; 2008 Jul; 86(1):36-45. PubMed ID: 18622276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function].
    Li X; Zhou ZG; Qi HY; Chen XY; Huang G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):419-23. PubMed ID: 16134594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of simple indices based on a single fasting blood sample as a tool to estimate beta-cell function after total pancreatectomy with islet autotransplantation - a prospective study.
    Gołębiewska JE; Bachul PJ; Fillman N; Basto L; Kijek MR; Gołąb K; Wang LJ; Tibudan M; Thomas C; Dębska-Ślizień A; Gelrud A; Matthews JB; Millis JM; Fung J; Witkowski P
    Transpl Int; 2019 Mar; 32(3):280-290. PubMed ID: 30353611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of our first nine intraportal islet allografts in type 1, insulin-dependent diabetic patients.
    Scharp DW; Lacy PE; Santiago JV; McCullough CS; Weide LG; Boyle PJ; Falqui L; Marchetti P; Ricordi C; Gingerich RL
    Transplantation; 1991 Jan; 51(1):76-85. PubMed ID: 1987709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.
    Rachman J; Payne MJ; Levy JC; Barrow BA; Holman RR; Turner RC
    Diabetes Care; 1998 May; 21(5):810-6. PubMed ID: 9589246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.